Author:
Venugopal N.,Vijaya Bhaskar Reddy A.,Gangadhar Reddy K.,Madhavi V.,Madhavi G.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference17 articles.
1. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective;Bolt;Toxicol. Lett.,2004
2. A rationale for determining testing and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity;Muller;Regul. Toxicol. Pharmacol.,2006
3. Toxicological overview of impurities in pharmaceutical products;Jacobson Kram;Adv. Drug Deliv. Rev.,2007
4. International Conference on Harmonization Quality Guidelines III/5442/94-EN ‘Impurities in New Drug Substances’ in the Federal Register, vol. 61,1996
5. EMEA-CHMP, Guidelines on the limit of genotoxic impurities CPMP/SWP/5199/02, EMEA/CHMP/QMP/251344/2006, 28 June, 2006.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献